TITLE

Pharmacokinetics of Cefepime Following Intravenous and Intramuscular Administration in Sheep

AUTHOR(S)
Patel, P. N.; Patel, U. D.; Bhavsar, Sh. K.; Thaker, A. M.
PUB. DATE
June 2010
SOURCE
Iranian Journal of Pharmacology & Therapeutics;2010, Vol. 9 Issue 1, p7
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Pharmacokinetics of cefepime was studied following single dose intravenous and intramuscular administration at the dose of 20 mg/kg of body weight in sheep. Drug concentration in serum was determined using high performance liquid chromatography (HPLC). Following single dose intravenous administration, the drug was rapidly distributed (t1/2α: 0.20 ± 0.02 h) and eliminated (t1/2β: 2.54 ± 0.12 h) from the body. The area under curve (AUC0-∞) was 135.50 ± 5.63 µg h/mL. The drug was cleared at the rate of 2.48 ± 0.09 mL/min/kg with mean residence time (MRT) of 2.84 ± 0.13 h. Following IM administration, the drug was rapidly absorbed (Cmax: 26.34 ± 1.44 µg/mL; tmax: 0.75 h) and slowly eliminated (t1/2β: 5.17 ± 0.44 h) from body. The volume of distribution at steady state (Vdss), area under curve (AUC), total body clearance (ClB) and mean residence time (MRT) were 1.11 ± 0.10 L/kg, 140.90 ± 8.67 µg h/mL, 0.15 ± 0.01 mL/min/kg and 6.89 ± 1.0 h, respectively. The bioavailability of cefepime following intramuscular administration was 103 ± 8.0 %.
ACCESSION #
82196889

 

Related Articles

  • Influence of the combination flunixin and marbofloxacin after its intramuscular administration on the pharmacokinetics of marbofloxacin in buffaloes (Preliminary study). Baroni, E. E.; Rodríguez, C.; M. D.San Andrés; Moroni, C.; Rubio, S.; de Lucas, J. J.; San Andrés, M. I. // Revista Veterinaria;2010, Vol. 21 Issue 1, p317 

    The pharmacokinetics of marbofloxacin was investigated in buffaloes given this drug alone o r in combination with flunixin. The study was carried out in eight (Two group 4 + 4) bu ffaloes (7-15 days old). Marbofloxacin was administered i.m. at a dosage of 2 mg.kg-1 alone o r in conjunction with...

  • Pharmacokinetics and safety of calcium L-threonate in healthy volunteers after single and multiple oral administrations. Wang, Hong-yun; Hu, Pei; Jiang, Ji // Acta Pharmacologica Sinica;Dec2011, Vol. 32 Issue 12, p1555 

    Aim:To evaluate the pharmacokinetics of L-threonate after single or multiple oral administrations and its safety profile in healthy Chinese volunteers.Methods:This was an open-label, single- and multiple-dose study. The subjects were assigned to receive a single dose, 675, 2025, or 4050 mg, of...

  • Determination of Pharmacokinetics of Flurbiprofen in Pakistani Population Using Modified HPLC Method. Qayyum, Aisha; Najmi, Muzammil Hasan; Farooqi, Zia-ur-Rehman // Journal of Chromatographic Science;Feb2011, Vol. 49 Issue 2, p108 

    Pharmacokinetics of flurbiprofen has been studied in different populations, especially in Caucasian. However, there are very few studies reported from Eastern part of world. Previous studies suggested that genetic and environmental factors may cause inter-individual differences in flurbiprofen...

  • Experimental study of the pharmacokinetics of a tryptophan-containing dipeptide GB-115. S. Boyko; G. Kolyvanov; V. Zherdev; T. Gudasheva; E. Kiryanova; S. Seredenin // Bulletin of Experimental Biology & Medicine;Sep2007, Vol. 144 Issue 3, p312 

    Abstract  Pharmacokinetics of an original compound GB-115 (N-phenylhexanoylglycyltryptophan) synthesized on the basis of the structure of endogenous tetrapeptide cholecystokinin-4 was studied by means of high-performance liquid chromatography. Pharmacokinetic parameters were calculated...

  • Bioequivalence Study of Donepezil Hydrochloride Tablets in Healthy Male Volunteers. Rojanasthien, Noppamas; Aunmuang, Siriluk; Hanprasertpong, Nutthiya; Roongapinun, Sukit; Teekachunhatean, Supanimit // ISRN Pharmacology;2012, p1 

    The objective of this study was to investigate the bioequivalence of two formulations of 5 mg donepezil HCL tablets: Tonizep as the test and Aricept as the reference. The two products were administered as a single oral dose according to a randomized two-phase crossover with a 3-week washout...

  • Pharmacokinetic and Tissue Distribution Study of Solid Lipid Nanoparticles of Zidovudine in Rats. Purvin, Shah; Vuddanda, Parameswara Rao; Singh, Sanjay Kumar; Jain, Achint; Singh, Sanjay // Journal of Nanotechnology;2014, p1 

    Zidovudine-loaded solid lipid nanoparticles (AZT-SLNs) and zidovudine in solution were prepared and administered in rats. The aim of this research was to study whether the bioavailability of zidovudine can be improved by AZT-SLNs perorally to rats as compared to oral administration of...

  • Pharmacokinetics and Bioavailability of Ceftriaxone in Patanwadi Sheep. Tiwari, S.; Patel, U. D.; Bhavsar, S. K.; Thaker, A. M. // VetScan;2010, Vol. 5 Issue 2, p45 

    Pharmacokinetics of ceftriaxone following single dose intravenous and intramuscular administration (10 mg/kg) in six Patanwadi sheep was determined. The plasma concentration-time curves were characteristic of a two and onecompartment open model following intravenous and intramuscular...

  • Analysis of Midazolam in Small Volumes of Plasma Using High Performance Liquid Chromatography and UV-Detection Method: Pharmacokinetics of Midazolam in Rats. Dengle, Swapnil J.; Pathak, Shriram M.; Mohan, Chandra; Karthik, Arumugam; Musmade, Prashant; Bhat, Krishnamurthy; Udupa, Nayanabhirama // Asian Journal of Research in Chemistry;Mar2011, Vol. 4 Issue 3, p406 

    This research work aims to exploit the high selectivity and sensitivity of UV detector to develop and validate a high performance liquid chromatography (HPLC) method having very small sampling volume, much better mass-sensitive detection limit and lower operating cost for the determination of...

  • Development and validation of a rapid method for the detection of latrunculol A in plasma. Shaw, Jiajiu; Valeriote, Frederick A.; Media, Joseph; Johnson, Tyler A.; Amagata, Taro; Tenney, Karen; Crews, Phillip // Analytical & Bioanalytical Chemistry;Mar2010, Vol. 396 Issue 5, p1741 

    Latrunculol A is a recently discovered 6,7-dihydroxy analog of the potent actin inhibitor latrunculin A. Latrunculol A has exhibited greater cytotoxicity than latrunculin A against both murine and human colon tumor cell lines in vitro. Currently, there are no reports regarding the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics